Aspiriant LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $280K | Sell |
|
|||||
|
2025
Q2 | $354K | Sell |
|
|||||
|
2025
Q1 | $471K | Buy |
|
|||||
|
2024
Q4 | $428K | Sell |
|
|||||
|
2024
Q3 | $419K | Buy |
|
|||||
|
2024
Q2 | $282K | Sell |
|
|||||
|
2024
Q1 | $495K | Buy |
|
|||||
|
2023
Q4 | $432K | Buy |
|
|||||
|
2023
Q3 | $439K | Sell |
|
|||||
|
2023
Q2 | $871K | Sell |
|
|||||
|
2023
Q1 | $995K | Sell |
|
|||||
|
2022
Q4 | $1.04M | Buy |
|
|||||
|
2022
Q3 | $925K | Buy |
|
|||||
|
2022
Q2 | $995K | Buy |
|
|||||
|
2022
Q1 | $745K | Sell |
|
|||||
|
2021
Q4 | $753K | Buy |
|
|||||
|
2021
Q3 | $453K | Sell |
|
|||||
|
2021
Q2 | $519K | Buy |
|
|||||
|
2021
Q1 | $487K | Buy |
|
|||||
|
2020
Q4 | $422K | Buy |
|
|||||
|
2020
Q3 | $390K | Buy |
|
|||||
|
2020
Q2 | $377K | Sell |
|
|||||
|
2020
Q1 | $381K | Sell |
|
|||||
|
2019
Q4 | $440K | Buy |
|
|||||
|
2019
Q3 | $312K | Sell |
|
|||||
|
2019
Q2 | $291K | Sell |
|
|||||
|
2019
Q1 | $382K | Sell |
|
|||||
|
2018
Q4 | $447K | Sell |
|
|||||
|
2018
Q3 | $605K | Sell |
|
|||||
|
2018
Q2 | $800K | Sell |
|
|||||
|
2018
Q1 | $1.35M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $978K | Sell |
|
|||||
|
2017
Q2 | $964K | Buy |
|
|||||
|
2017
Q1 | $905K | Buy |
|